Deutsche Bank’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History
Bought
Maintained
Sold
Other funds holding SEEL
SM
GJL
WE
MWM
WP
Deutsche Bank's SEEL Position: Q3 2023 in Review
Deutsche Bank sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q3 2023, closing a stake of 8 shares — an estimated $36.5K sold.
Deutsche Bank first reported a position in SEEL in Q2 2021 and held it in 9 quarters. The position peaked at $746K in Q2 2021. 67 funds tracked by Wall St. Rank hold SEEL as of Q3 2023.
- Deutsche Bank reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Deutsche Bank sold 8 Seelos Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $36.5K.
- Deutsche Bank first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2021 and held it in 9 quarters.
- Deutsche Bank's Seelos Therapeutics, Inc. Common Stock position peaked at $746K in Q2 2021.
- 67 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Deutsche Bank's 13F filing for Q3 2023, filed 9 Nov 2023.